Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
- Conditions
- Recurrent CancerRefractory CancerChildhood CancerChildhood Brain TumorChildhood Solid Tumor
- Interventions
- Drug: Paxalisib, Irinotecan, Temozolomide
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2025-02-21
- Target Recruit Count
- 82
- Registration Number
- NCT06208657
- Locations
- 🇦🇺
John Hunter Children's Hospital, Newcastle, New South Wales, Australia
🇦🇺Sydney Children's Hospital, Randwick, Sydney, New South Wales, Australia
🇦🇺The Children's Hospital at Westmead, Sydney, New South Wales, Australia
Precision Medicine for Every Child With Cancer
- Conditions
- Childhood Solid TumorChildhood LeukemiaRefractory CancerChildhood CancerChildhood Brain TumorRelapsed Cancer
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2024-07-17
- Target Recruit Count
- 3500
- Registration Number
- NCT05504772
- Locations
- 🇦🇺
Women's and Children's Hospital, Adelaide, Australia
🇦🇺Queensland Children's Hospital, Brisbane, Australia
🇦🇺Royal Hobart Hospital, Hobart, Australia
A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT
- Conditions
- Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorRecurrent Brain Tumor, ChildhoodMalignant Rhabdoid Tumor
- Interventions
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-02-24
- Target Recruit Count
- 25
- Registration Number
- NCT04897880
- Locations
- 🇺🇸
The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States
🇦🇺John Hunter Children's Hospital, New Lambton, New South Wales, Australia
🇦🇺Sydney Children's Hospital, Randwick, New South Wales, Australia